secwatch.observer — SEC 8-K summary
======================================

Issuer:     EXACT SCIENCES CORP (—)
CIK:        0001124140
Form:       8-K
Filed at:   2026-03-23T23:59:59+00:00
Accession:  0001193125-26-118700
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.85
Item codes: 1.01, 1.02, 2.01, 3.01, 3.03, 5.01, 5.02, 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Abbott completes acquisition of Exact Sciences for $105/share cash, ~$21B
-------------------------------------------------------------------------

- Merger effective March 23, 2026; each Exact share converted into $105.00 cash without interest.
- Total merger consideration approximately $21 billion, funded via cash on hand and debt.
- All Exact directors resigned at effective time; officers ceased positions.
- Outstanding options, RSUs, and performance units cashed out or assumed by Abbott.
- Exact's convertible notes now convertible solely into cash based on $105 conversion rate; stock delisted from Nasdaq.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1124140/000119312526118700/0001193125-26-118700-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1124140/000119312526118700/d128802d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-118700

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer